RUSSO, EDDA
 Distribuzione geografica
Continente #
EU - Europa 1.553
NA - Nord America 1.545
AS - Asia 415
AF - Africa 5
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.525
Nazione #
US - Stati Uniti d'America 1.533
PL - Polonia 738
IT - Italia 321
IE - Irlanda 217
HK - Hong Kong 192
SE - Svezia 161
CN - Cina 69
JO - Giordania 54
VN - Vietnam 29
IN - India 28
SG - Singapore 26
DE - Germania 21
GB - Regno Unito 18
RU - Federazione Russa 15
CH - Svizzera 14
FR - Francia 14
FI - Finlandia 12
CA - Canada 10
NL - Olanda 7
TR - Turchia 7
ES - Italia 6
JP - Giappone 5
UG - Uganda 5
UA - Ucraina 4
AU - Australia 3
BE - Belgio 2
BR - Brasile 2
KR - Corea 2
MX - Messico 2
AT - Austria 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
UZ - Uzbekistan 1
Totale 3.525
Città #
Warsaw 736
Chandler 217
Dublin 212
Fairfield 171
Ashburn 135
Hong Kong 134
Seattle 94
Florence 80
Woodbridge 80
Houston 79
New York 78
Wilmington 68
Cambridge 55
Lawrence 51
Altamura 48
Beijing 41
Princeton 39
Ann Arbor 31
Fiesole 30
Boston 26
Dong Ket 25
Pune 25
Singapore 25
Buffalo 22
San Diego 18
Shanghai 17
Medford 16
Bern 13
Boardman 13
Moscow 13
Falls Church 9
Hillsboro 9
Toronto 8
London 7
Milan 7
Rome 7
Norwalk 6
Castelliri 5
Izmir 5
Jacksonville 5
Kampala 5
Phoenix 5
Redwood City 5
Washington 5
Andover 4
Bagno a Ripoli 4
Romainville 4
San Francisco 4
Bologna 3
Bremen 3
Dearborn 3
Fuzhou 3
Menlo Park 3
Paris 3
Scarperia e San Piero 3
Takasago 3
Turin 3
Adelfia 2
Agliana 2
Amsterdam 2
Arezzo 2
Aversa 2
Barcelona 2
Brussels 2
Calenzano 2
Cartama 2
Cesena 2
Chiswick 2
Cincinnati 2
Gainesville 2
Gazzo 2
Greve in Chianti 2
Guelph 2
Hounslow 2
Huskvarna 2
Kayseri 2
Lonato 2
Montargis 2
Morelia 2
Nanjing 2
Pinerolo 2
Prato 2
Russi 2
Scandicci 2
Schio 2
Sesto Fiorentino 2
Siena 2
Signa 2
Sydney 2
São Paulo 2
Terni 2
Thrissur 2
Tokyo 2
Yongin-si 2
Arenys de Mar 1
Atlanta 1
Bergamo 1
Campi Bisenzio 1
Catania 1
Chicago 1
Totale 2.803
Nome #
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 243
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 241
null 181
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 161
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 133
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 128
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 122
Multiplex gene expression profile in inflamed mucosa of patients with Crohn’s disease ileal localization: A pilot study 117
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 115
Evaluation and comparison of short chain fatty acids composition in gut diseases 115
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 97
Role of diet and gut microbiota on Colorectal cancer immunomodulation 90
The interplay between the microbiome and the adaptive immune response in cancer development 79
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 77
Exploring the food-gut axis in immunotherapy response of cancer patients 76
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 73
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 68
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 65
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 61
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 58
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 55
A two-stage strategy for early and accurate detection of B. cepacia in routine clinical analysis involving CF patients. Identification of Burkholderia cepacia strains by LAMP and SNuPE 47
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 47
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 46
Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients 43
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 41
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 40
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 39
Structural, functional and evolutionary analysis of histidine biosynthetic genes in Burkholderia strains 39
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 39
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 38
Identification of Burkholderia cepacia complex species by LAMP or SNuPE analysis of his genes 37
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 36
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 35
Involvement of MIR-126 and MMP9 in the Pathogenesis of Intra-Abdominal Fistulizing Crohn’s Disease: A Brief Research Report 34
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 34
Thyroidectomy for cancer: The surgeon and the parathyroid glands sparing 31
Identification of Burkholderia cepacia complex species by Loop Mediated Isothermal Amplification (LAMP) or Single Nucleotide Primer Extension (SNuPE) analysis of his genes 29
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 29
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 28
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 27
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 27
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study 27
LYSOZYME INTERACTION WITH NEGATIVELY CHARGED LIPID BILAYERS: PROTEIN AGGREGATION AND MEMBRANE FUSION 27
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 26
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 26
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma 26
On the origin and evolution of operons: the piece-wise assembly of histidine biosynthetic genes in proteobacteria 26
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 24
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 23
Is the age at surgery in Crohn's disease clinically relevant? Differences and peculiarities: a wide single centre experience after long-term follow-up 22
Circulating Calprotectin (cCLP) in autoimmune diseases 21
Crohn's disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors 21
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 19
Microbiota and viral hepatitis: State of the art of a complex matter 19
Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control 18
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 16
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 16
Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study 14
JAK inhibitors and autoimmune rheumatic diseases. 14
Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) 12
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 12
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases 11
Surgery for Sporadic Primary Hyperparathyroidism: Evolution over the Last Twenty Years in a Monocentric Setting 10
Effects of the learning curve on operative time and lymph node harvesting during robotic gastrectomy 10
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease 10
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 9
Inadequate food literacy is related to the worst health status and limitations in daily life in subjects with inflammatory bowel disease 9
Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1 9
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 8
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 8
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective 5
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 5
Effects of the learning curve on operative time and lymph node harvesting during robotic gastrectomy 5
Totale 3.629
Categoria #
all - tutte 14.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201980 0 0 0 0 0 0 0 0 0 18 38 24
2019/2020602 25 30 13 52 73 69 65 77 64 48 77 9
2020/2021568 42 50 42 72 33 50 32 39 53 92 26 37
2021/2022283 10 10 16 17 7 18 10 31 20 10 53 81
2022/20231.116 69 175 30 72 80 174 141 67 122 42 79 65
2023/2024683 27 46 89 46 62 164 35 169 12 33 0 0
Totale 3.629